Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LAWRENCEVILLE, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, today announced financial results for the year ended December 31,...
-
BEIJING, March 15, 2017 (GLOBE NEWSWIRE) -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of cloud-based data analytics solutions in China, today reported its...
-
PLYMOUTH MEETING, Pa., March 15, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the fourth quarter and year ended December 31, 2016. Total...
-
BRISBANE, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
BRISBANE, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
PERSBERICHT: 15 maart 2017, 07:00 CET Biocartis ontvangt subsidie voor ontwikkeling van volledig geautomatiseerde MSI test Test zou...
-
PRESS RELEASE: 15 March 2017, 07:00 CET Biocartis receives grant for development of a fully automated MSI test Test could be validated...
-
Hyderabad, India, March 14, 2017 (GLOBE NEWSWIRE) -- The report “Healthcare Outsourcing Market: By Type (Healthcare Payer and Provider, Pharmaceutical, Pathology and Labs); By Region & By...
-
BRISBANE, Calif., March 14, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
-
– Brings Together Eye Care and CRISPR Innovators to Develop Transformative Medicines for Patients – – Provides Allergan Exclusive Access to Multiple Editas Medicine Ocular Programs Based on its...